RCUS 股东权益历史(2017–2025)
Arcus Biosciences, Inc. (RCUS) 各财年年末股东权益(来自 SEC 财报)。
$631.0MFY2025 · FY2017 以来:-$72.3M → $631.0M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $631.0M | +30.1% |
| FY2024 | $485.0M | +5.0% |
| FY2023 | $462.0M | -29.7% |
| FY2022 | $657.0M | -22.0% |
| FY2021 | $842.0M | +67.7% |
| FY2020 | $502.0M | +206.1% |
| FY2019 | $164.0M | -30.2% |
| FY2018 | $234.9M | +424.8% |
| FY2017 | -$72.3M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议